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Abstract
Background: During the development of a therapeutic antibody, large numbers of monoclonal antibodies are
required to screen for those that are best suited for the desired activity. Although the single cell-based
immunoglobulin variable gene cloning technique is a powerful tool, the current methods remain an obstacle to
the rapid production of large numbers of recombinant antibodies.
Results: We have developed a novel overlap extension polymerase chain reaction, the target-selective joint
polymerase chain reaction (TS-jPCR), and applied it to the generation of linear immunoglobulin gene expression
constructs. TS-jPCR is conducted using a PCR-amplified immunoglobulin variable gene and an immunoglobulin
gene-selective cassette (Ig-cassette) that contains all essential elements for antibody expression and overlapping
areas of immunoglobulin gene-specific homology. The TS-jPCR technique is simple and specific; the 3’-random
nucleotide-tailed immunoglobulin variable gene fragment and the Ig-cassette are assembled into a linear
immunoglobulin expression construct, even in the presence of nonspecifically amplified DNA. We also developed a
robotic magnetic beads handling instrument for single cell-based cDNA synthesis to amplify immunoglobulin
variable genes by rapid amplification of 5’ cDNA ends PCR. Using these methods, we were able to produce
recombinant monoclonal antibodies from large numbers of single plasma cells within four days.
Conclusion: Our system reduces the burden of antibody discovery and engineering by rapidly producing large
numbers of recombinant monoclonal antibodies in a short period of time.
Background
Recombinant monoclonal antibody technology com-
prises a series of molecular approaches that allows for
the production of therapeutic antibodies [1,2]. Molecular
cloning and expression of polymerase chain reaction
(PCR)-amplified immunoglobulin variable (V) genes
from single, isolated primary B cells provide powerful
tools for the generation of recombinant monoclonal
antibodies [3,4]. Introduction of the PCR-amplified V
gene fragments into expression plasmids has been per-
formed using traditional cut-and-paste DNA cloning
techniques [5-9]. Recently, site-specific recombination
and homologous recombination cloning techniques,
which eliminate the use of restriction endonucleases and
ligases, offer several advantages in the context of high-
throughput procedures [10-14]. These methods, how-
ever, still require plasmid amplification in bacteria, fol-
lowed by plasmid purification and verification of the
insert.
Because of the need for a more convenient method for
the generation of recombinant antibodies, the overlap
extension polymerase chain reaction method (overlap
PCR) has been developed. In this method, a PCR-ampli-
fied V gene fragment is joined to DNA cassettes by
PCR to build a linear immunoglobulin gene expression
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(Ig-expression) construct [15-17]. While the current
overlap PCR method is rapid compared with traditional
plasmid-based cloning methods, it still has several lim-
itations. One of the major drawbacks of this method is
that the PCR-amplified V gene fragment must be puri-
fied to remove primers and nonspecifically amplified
DNA fragments to achieve successful production of Ig-
expression constructs. Because short homology overlaps
within the ends of DNA cassettes are generated at the
ends of PCR-amplified DNA fragments with primers,
both V gene fragments and nonspecifically amplified
PCR products are joined to the DNA cassettes. Another
problem is this technique’s complicated joining reaction
in which a promoter cassette, the purified V gene frag-
ment and a terminator cassette must be assembled in a
specific order based on their short homology overlaps.
This process sometimes results in a low yield of Ig-
expression constructs. Therefore, a more efficient sys-
tem that bypasses these tedious steps is required to gen-
erate recombinant antibodies from large numbers of
single, isolated cells.
This study describes a novel overlap PCR method
termed target-selective joint PCR (TS-jPCR). With this
method, a PCR-amplified V gene fragment can be selec-
tively assembled into a linear Ig-expression construct,
even in the presence of nonspecifically amplified DNA
fragments. TS-jPCR is accomplished by joining the 3’-
random nucleotide-tailed V gene fragment and an
immunoglobulin-selective cassette (Ig-cassette). The Ig-
cassette contains all the essential elements for antibody
expression and V-gene-specific long homology overlaps
within a single DNA molecule.
We also developed a robotic magnetic head handling
instrument (MAGrahder) that allows for automated sin-
gle cell-based cDNA synthesis and 3’ end homopolymer
tailing using the MAGrahd method [18]. The MAGrah-
der is a non-contact magnetic power transmission
instrument in which 12-channel, parallel magnetic rods
installed on a robotic arm transport nucleic acid-bound
magnetic beads in a MAGrahd reactor tray. Using
MAGrahder and TS-jPCR, we were able to produce
recombinant monoclonal antibodies from large numbers
of single plasma cells within four days (Figure 1).
Results
Development of TS-jPCR
To evaluate the performance of TS-jPCR, we conducted a
pilot experiment using an artificially amplified mouse V
gene and a mock DNA fragment (Figure 2). The mock
DNA fragment served as a model for a nonspecifically
amplified DNA fragment and was composed of an upper
PCR primer (P1), a green fluorescent protein (GFP) gene
segment and a lower PCR primer (P2) sequence. The V
gene fragment was composed of the P1 sequence, a poly
dG/C sequence (T1), a mouse immunoglobulin heavy
chain variable sequence, part of the constant gene
sequence (T2) and the P2 sequence. The T1 and T2
sequences are specific regions of V gene fragment ampli-
fied by the rapid amplification of 5’ cDNA ends PCR (5’-
RACE PCR). An Ig-cassette contains all essential ele-
ments for expression of the antibody, including the CMV
promoter, the immunoglobulin chain constant region
and the poly (A) signal. Additionally, the cassette has
long overlapping regions of immunoglobulin gene-speci-
fic homology on its ends (VP1VT1 and VP2VT2). VT1
(VT2) sequence localizes at the end of the Ig-cassette and
shares homology with T1 (T2) sequence. VP1 (VP2)
sequence localizes internally to the VT1 (VT2) sequence
and shares homology with P1 (P2) sequence. Before the
Figure 1 A flow chart summarizing the high-throughput
production of recombinant antibodies from single plasma cells.
Single cell-based cDNA synthesis was performed by MAGrahd. V
genes were amplified from the cDNA by 5’-RACE PCR (Day 1). The
PCR products were treated with TdT for 3’-end random nucleotide
tailing. The reaction products were then mixed with Ig-cassettes to
generate linear Ig-expression constructs by TS-jPCR. Cognate pairs of
IgH- and IgL-expression constructs were then directly transfected
into 293FT cells (Day 2). The V-(D)-J repertoire and IgG subclass were
determined by direct sequencing (Days 3-4). The concentration and
activity of the recombinant antibodies were determined by ELISA
(Day 4). Pro, promoter; pA, poly(A) site; const, immunoglobulin
constant region; NNN, 3’-end random-nucleotide tail.
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joining of these DNA fragments to the Ig-cassette, each
DNA fragment was tailed with random nucleotides on its
3’ end using a terminal deoxynucleotidyl transferase
(TdT). As shown in Figure 3, the joining of the tailed V
gene fragment to the Ig-cassette by TS-jPCR resulted in
the amplification of a single major band corresponding to
the expected size of the linear Ig-expression construct.
When TS-jPCR was conducted with the tailed mock
DNA fragment and the Ig-cassette, no amplification pro-
duct was detected. When TS-jPCR was conducted with
the cassette and a mixture of the V gene and the mock
DNA fragment (1:1 molar ratio), a single major band cor-
responding to the expected size was detected (Figure 3A).
To examine whether the amplified band resulted from
the Ig-cassette joining to the V gene, the mock or both,
we performed direct sequencing. As shown in Figure 3B,
the sequencing showed a clear chromatograph pattern
that corresponded to the V gene sequence. Furthermore,
no insertion or deletion at the joint junctions was found.
These results clearly confirm the high selectivity of the
TS-jPCR method, even in a case in which the nonspecific
amplification happened to be the same size as the V gene
fragment.
The scheme in Figure 4 explains the mechanism that
enables the selective joining of TS-jPCR. When TS-jPCR
is conducted, the melted strands of the Ig-cassette and
the V gene fragment partially hybridize with each other
via the long homology overlaps (P1T1 to VP1VT1 and
P2T2 to VP2VT2) to generate stable hybrid duplexes.
Each of the hybridized cassette strands that contain the
V gene-specific sequence at the 3’ ends (VT1 or VT2)
can serve as a primer for strand extension, which leads
to the generation of an Ig-cassette-V gene fusion strand
in each hybrid duplex. However, each of the hybridized
V strands that contain 3’-end random nucleotide tails
fails to serve as a primer (1st PCR cycle). After denatur-
ing the hybrid duplexes, the melted fusion strands par-
tially hybridize with each other via the complementary
V gene sequences, which leads to the generation of a
double-strand DNA that is composed of two copies of
the Ig-cassette joined to each end of the V gene in a
head-to-tail orientation (2nd PCR cycle). This repeating
unit facilitates partial hybridization of each strand,
which leads to the generation of an Ig-cassette-V gene
concatemer (3rd to 5th PCR cycle). Until the end of the
fifth PCR cycle, the P3 and P4 PCR primers used for
amplification of an Ig-expression construct do not
hybridize with their complementary strands because of
the high annealing temperature. Conducting the follow-
ing 30 additional PCR cycles at a low annealing tem-
perature allows the P3 and P4 PCR primers to hybridize
with their complementary strands, which leads to ampli-
fication of the Ig-construct.
When TS-jPCR is conducted with the Ig-cassette and
the tailed mock DNA, the melted strands of the Ig-cas-
sette and mock DNA partially hybridize with each other
via their short homology overlaps (P1 to VP1 and P2 to
VP2) to generate unstable hybrid duplexes. It is impor-
tant to note that these structures render the polymerase
unable to extend any strands because of the 3’-end mis-
matches. Therefore, nonspecifically amplified DNA that
lacks the V gene-specific sequence (T1 and T2) internal
to the primer-derived sequence (P1 and P2) is unable to
be joined to the Ig-cassette (Figure 4B).
High-throughput amplification of immunoglobulin
variable genes
Single cell-based cDNA synthesis is a costly and time-
consuming process for the production of recombinant
monoclonal antibodies from large numbers of single
cells. To speed up this process, we developed an auto-
matic non-contact magnetic power transmission
Figure 2 Schematic illustration of DNA fragments and primer
positions. (A) 3’-end poly dG-tailed cDNA and primers used for the
amplification of V genes by 5’-RACE PCR. Arrows represent the
position and orientation of the primers. dC13 is the first-round PCR
forward primer specific for the poly dG-tailed cDNA, and P0 is the
first-round PCR reverse primer specific for the respective IgG or IgK
constant regions. P1 is the second round PCR forward primer, and
P2 is the second round PCR reverse primer specific for the IgG or
IgK constant regions. (B) Schematic representation of homology
overlaps between the Ig-cassette and DNA fragments. The Ig-
cassette contains V gene-specific sequences (VT1 and VT2) external
to the primer-derived sequences (VP1 and VP2). The V gene
contains specific sequences (T1 and T2) for the 5’-RACE PCR-
amplified V gene internal to the primer-derived sequences (P1 and
P2). The mock DNA has P1 and P2 sequences at its ends. P3 and P4
PCR primers hybridize to the f1 replication origin of the Ig-cassette
and are used for amplifying the Ig-expression constructs.
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instrument, MAGrahder. MAGrahder is composed of a
MAGrahd reactor tray and a desktop robot. The
MAGrahd reactor tray can be assembled from a reusa-
ble tray and a single-use super-hydrophobic film upon
which a 24 × 8 grid of cup-shaped structures to hold
drops are embossed (Figure 5). The robot provides a
tip- and tube-free platform that allows magnetic beads
to be transferred between arrayed hanging drops depos-
ited on the cup-shaped structures of the super-hydro-
phobic film with an externally applied magnetic force.
MAGrahder has 12-channel, parallel magnetic rods
installed on a robotic arm, which transports and mixes
nucleic acid-bound magnetic beads in MAGrahd reactor
trays (Figure 6). The instrument performs mRNA
extraction, reverse transcription and the homopolymer-
tailing reaction and is capable of handling up to 144
samples per instrument, in parallel, within an hour by
touching neodymium permanent magnet rods to the
opposite side of the thin glass surface of the MAGrahd
reactor tray above the drops. We prepared 3’-end homo-
polymer-tailed cDNA from isolated single plasma cells
and used them as templates to amplify immunoglobulin
heavy chain variable (VH) and immunoglobulin light
chain variable (VL) genes by 5’-RACE PCR. As shown in
Figure 7A, 5’-RACE PCR resulted in the successful
amplification of the cognate pair of VH and VL genes
with an overall success rate of 100%.
Application of TS-jPCR for the production of recombinant
mouse antibodies
We next attempted to demonstrate the utility of TS-
jPCR by producing Ig-expression constructs from
Figure 3 Pilot experiment showing the selective joining of a V gene to the Ig-cassette by TS-jPCR. (A) An agarose gel stained with
ethidium bromide showing the TS-jPCR results. Lane 1: Ig-cassette, lane 2: tailed mock DNA fragment, lane 3: tailed V gene fragment, lane 4:
mixture of the mock and V gene fragments, lane 5: amplified product with the Ig-cassette and water, lane 6: amplified fragment with the Ig-
cassette and mock DNA fragment, lane 7: amplified fragment with the Ig-cassette and V gene fragment, lane 8: amplified fragment with the Ig-
cassette and a mixture of mock DNA and V gene fragments. Lanes 5-8: each lane contains 1 μl from a 25-μl PCR. The arrow indicates the size of
the Ig-expression construct. M, 1 kb DNA ladder. (B) DNA sequence chromatogram of the fragment in lane 8. The arrow indicates the boundary
between the V gene and the Ig-cassette. The blue horizontal bar indicates the heavy chain constant sequence, and the red bar indicates the
variable sequence.
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amplified V genes. After 3’-end random nucleotide tail-
ing of the 5’-RACE PCR products, they were joined to
the respective Ig-cassette using TS-jPCR. As shown in
Figure 7B, TS-jPCR resulted in the amplification of sin-
gle major bands corresponding to the expected sizes of
IgG- and IgK-expression constructs. The joining success
rate was 100% in both IgG and IgK. When we trans-
fected the cognate pair of unpurified Ig-expression con-
structs into 293FT cells, expression of the recombinant
monoclonal antibodies was detected in all examined
samples (Figure 7C). Analysis of the antigen binding
activity of the recombinant antibodies revealed that
Figure 4 Schematic illustration of TS-jPCR. (A) Diagram showing the specific V gene joining with the Ig-cassette. (B) Diagram showing the
mechanism by which TS-jPCR inhibits the joining of nonspecifically amplified DNA to the Ig-cassette. P3 and P4 are primers that hybridize to
the f1 replication origin sequence localized between the CMV promoter and the poly (A) signal under a low annealing temperature. NNN
indicates the 3’-end random-nucleotide tail.
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eight clones specifically reacted with the antigen (Figure
7D). Because of the high selectivity of TS-jPCR, we next
attempted to determine the V-(D)-J repertoire of the
assembled V genes. Direct sequencing of the Ig-expres-
sion constructs was readily achieved with an overall
sequencing success rate of 96% (Figure 8). The sequen-
cing failed in only two cases of VH (37 and 49) and two
cases of VL (33 and 37). Cloning of the corresponding
5’-RACE PCR products into plasmids revealed that
these fragments contained pseudo V gene segments that
had T1 and T2 sequences internal to the P1 and P2
sequences.
Discussion
We have established TS-jPCR and used it for the rapid
production of recombinant monoclonal antibodies from
mouse plasma cells. While the principle of this
procedure is essentially the same as other recently
reported PCR-based methods, TS-jPCR has several use-
ful features that overcome the limitations of the current
methods. First, purification of the amplified V genes
represents a significant, major bottleneck for the high-
throughput production of recombinant antibodies. In
contrast, TS-jPCR enables the production of Ig-expres-
sion constructs, even in cases where the nonspecific
amplification product happens to be the same size as
the V genes. Second, current PCR-based methods some-
times suffer low Ig-expression construct yields. This
result is likely due to inefficient hybrid duplex formation
between the V gene and the promoter or terminator
cassette, which is mediated through their short homol-
ogy overlaps (~25 bp). TS-jPCR can produce a sufficient
amount of linear expression construct for DNA trans-
fection and direct sequencing by using a single cassette
Figure 5 Design and assembly of the MAGrahd reactor tray. (A) Flow diagram for the set-up of the MAGrahd device.(i) The upper tray plate
of an Omni tray (Nunc) was cut into a rectangular shape (49 mm × 110 mm). (ii) The opening was fixed with a cover glass plate from the
inside of the lid. (iii) The fabricated film was bound to the inner surface of the thin glass plate. (iv) All of the reagents were dispensed onto the
grids of the super-hydrophobic film. (v) The upper tray was inverted and attached to the bottom reservoir tray. (B) Design of the master stamp
for embossing an array of grids onto a sheet of super-hydrophobic film. (1) An aluminum master and (2) a silicone plate. (C) Schematic drawing
of an array of grids on a super-hydrophobic film.
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that has long and specific homology overlaps (over 50
bp) at both ends.
Several methods for single cell-based cDNA synthesis
have been reported to amplify V genes by 5’-RACE PCR,
including the use of multi-well methods [19]. However,
these methods generally require manual input, thereby
limiting the throughput of the experiment and increasing
the susceptibility to cross-contamination and nonspecific
amplification. The MAGrahder provides more effective
single cell-based cDNA synthesis by using a non-contact
automatic magnetic power transmission system in which
the magnetic beads are transported and mixed by the
combined action of magnetic and gravitational fields in
the hanging drop. The advantage of MAGrahd is that high
quality cDNA synthesis for downstream applications can
be achieved in a short time because nucleic acid-bound
magnetic beads were separated from residual contami-
nants, such as salts, nucleotides and enzymes, by extract-
ing the beads from the drops. Additionally, the MAGrahd
reactor tray protects against cross-contamination because
all steps were proceed in a pipet tip-free environment in a
closed space. Furthermore, the technical variation is signif-
icantly decreased when compared to a corresponding
manual experiment, which results in the successful ampli-
fication of V genes by 5’-RACE PCR. The fact that the
gene amplification unit is not integrated may be consid-
ered a disadvantage of MAGrahder. However, the collec-
tion of cDNAs from the MAGrahd reactor tray can be
easily transferred into the wells of a 96- or 384-well PCR
plate with a twelve-tipped pipettor. Given the time
Figure 6 Design of robotic magnetic bead handling instrument (MAGrahder). (A) A lateral view shows how magnetic beads are extracted
from a drop, transferred into the next drop and mixed by MAGrahder. When the neodymium permanent magnet rod contacts the thin glass
surface of the MAGrahd reactor tray from outside near the drops, the magnetic beads in the drops collect at the surface of the glass plate. The
beads are then transported to subsequent drops where they are released by removing the magnetic rod from the glass plate. (B) A lateral view
of the MAGrahd tray reactor after set-up. (C) General view of the MAGrahder. (1) Computer control; (2) the deck of the ShotMaster 300 that is
equipped with six MAGrahd reactor trays; (3) robotic arm; (4) temperature controller. (D) Image of the robotic arm with 12-channel magnetic
rods transferring magnetic beads in the MAGrahd reactor tray.
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required for PCR, it is far more efficient for the machine
to solely operate for cDNA synthesis. Thus, there is no
need to include the gene amplification unit into
MAGrahder.
We recently developed a target-selective homologous
recombination cloning method (TS-HR) for the single-
step insertion of PCR-amplified V gene fragments into
expression vectors [18]. Because TS-HR is a plasmid-
based cloning method, TS-jPCR is preferable to TS-HR
in the context of high-throughput production of large
numbers of recombinant antibodies. Once recombinant
monoclonal antibodies with the desired specificity have
been obtained by screening, the corresponding V genes
can be inserted into an expression plasmid by TS-HR,
which can in turn be used for large-scale antibody
production.
Conclusion
Starting from fifty-three isolated mouse plasma cells, we
achieved amplification of the VH and VL genes within a sin-
gle day. On the next day, each of the amplified V genes was
joined to an Ig-cassette by TS-jPCR to generate Ig-expres-
sion constructs that can be used for DNA transfection and
direct sequencing. Our methods are directly applicable to
rapid and scalable automation for the generation of large
numbers of recombinant monoclonal antibodies.
Methods
Materials
Dynabeads oligo(dT)25 magnetic beads, Dulbecco’s
Modified Eagle’s Medium, SuperScript III Reverse Tran-
scriptase and One-shot TOP10 competent cells were
obtained from Invitrogen. Super-hydrophobic film was
Figure 7 High-throughput production of IgH- and IgL-expression constructs by TS-jPCR. (A) Ethidium bromide-stained agarose gels of the
cognate pairs of VH and VL genes amplified from single plasma cells. Each lane contains 1 μl of a 25-μl VH or VL 5’-RACE PCR product.
Representative PCR products from fifty-three samples are shown. H, heavy chain V gene fragment; L, light chain V gene fragment. (B) Agarose
gels stained with ethidium bromide showing the TS-jPCR results. VH and VL genes obtained in (A) were treated with TdT and joined to the
corresponding Ig-cassette. Each lane contains 1 μl of a 25 μl IgH- or IgL-expression construct. The fainter high-molecular weight bands are
presumed to be a multimer of the correct band. Representative PCR products from fifty-three samples are shown. H, IgH-expression construct; L,
IgL-expression construct. (C) Production of recombinant mouse monoclonal antibodies. Cognate pairs of IgH- and IgL-expression constructs (1 μl
each) were directly transfected into 293FT cells. The concentration of the recombinant antibodies in the cell culture media was determined by a
sandwich ELISA two days after the transfection (left panel). Antigen specificity against egg albumin is expressed as luminescence activity (right
panel). The specific activity of recombinant antibodies is expressed as relative light units (RLU/s/IgG (μg)). N indicates a negative control; all
incubation steps were identical except that nontransfected cell culture medium was used.
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obtained from Alcan Packaging. The FuGENE® HD
Transfection Reagent and TdT were obtained from
Roche Applied Science. PrimeSTAR™ HS DNA Poly-
merase was obtained from Takara Bio. Restriction
enzymes were obtained from New England Biolabs.
Titermax Gold Adjuvant was obtained from CytRx Cor-
poration. A SHOTMASTER 300 desktop robot was
purchased from Musashi Engineering. The animal
experiment was approved by the Committee on Animal
Experimentation at Toyama University.
Plasmid construction
A DNA fragment encoding 901 bp of the mouse immu-
noglobulin gamma (IgG) constant region (559-1460 of
Figure 8 V-(D)-J repertoire of the assembled V genes. Linear IgH- and IgK-expression constructs were directly sequenced, and the V-(D)-J-(H)
repertoires were determined. The sequence primers used were P2.
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nucleotide accession number: AB097849) was amplified
with the primers 5’– GATATCACGTGTGCCTGGT-
CAAGGGCTATTTCCCTGAG-3’ and 5’–
CTCCGCGGCCGCTGGGATCATTTACCAGGAGAGT
-3’ (restriction sites underlined). A DNA fragment
encoding 309 bp of the mouse immunoglobulin kappa
(IgK) constant region (441-750 of nucleotide accession
number: AF466770) was amplified with the primers 5’–
GATATCACGTGCTGTATCCATCTTCCCACCATCC
-3’ and 5’–TCTCGCGGCCGCTGTCTCTAACACT-
CATTCCTG-3’. A DNA fragment containing the pUC
replication origin, an ampicillin resistance gene and a
SacB gene was amplified from pDNR (Takara-Clontech)
by PCR with the primers 5’-AGAGAGACCCGGGC-
CAGGAACCGTAAAAAGGCCG-3’and 5’-AGAGA-
GACCCGGGACGTCCACATATACCTGCC-3’. The
dC13/dG13 linker DNA was made by annealing the oli-
gonucleotides 5’–GATCCCCCCCCCCCCCGATATC-3’
and 5’–GATCGATATCGGGGGGGGGGGG -3’. The
dC13/dG13 linker, the pDNR-derived DNA fragment
and the mouse IgG constant gene fragment were
inserted into the Bam HI/Not I site of pGFP N1 plasmid
(Clontech). The pJON-mIgG plasmid was generated
from the resulting plasmid by removing the pEGFP N1-
derived sequence spanning from the kanamycin gene to
the pUC replication origin by PCR. The pJON-mIgK
plasmid was constructed with the dC13/dG13 linker, the
pDNR-derived DNA fragment and the mouse IgK con-
stant gene fragment in the same manner. A map of the
plasmids is shown in Figure 1. The DNA cassette for
the mouse VH (IgH-cassette) was amplified from pJON-
mIgG plasmid with the primers 5’-GGGGGGGGGG
GGGGGGGATCCCGG-3’ and 5’-GCCTGGTCAAGG
GCTATTTCCCTGAG-3’. The DNA cassette for the
mouse VL (IgK-cassette) was amplified from pJON-
mIgK plasmid by PCR with the primers 5’-GGGG
GGGGGGGGGGGGGATCCCGG-3’ and 5’-CTGTATC-
CATCTTCCCACCATCCAGT-3’. The amplified cas-
settes were treated with Dpn I to digest the template
plasmid and then purified using a S-400 spin column.
Design and fabrication of the MAGrahd reactor tray
The MAGrahd reactor tray consists of three components:
drops, magnetic beads and a super-hydrophobic film-
layered tray. The upper tray plate of an Omni tray
(Nunc) was cut in a rectangular shape and was fixed to a
thin glass cover plate (Matsunami, No. 1, 73 mm × 118
mm, 0.1 mm thickness) instead of a plastic board. Super-
hydrophobic film was fabricated by pressing the film with
an aluminum master stamp that contained the positive
relief features against a silicone plate. The master stamp
used here was made using a standard end mill process.
The fabricated film has a 24 × 8 grid of positive relief fea-
tures, which capture drops on a planer surface. The grid
consists of two arcs that are arranged to form a cup-
shaped enclosure with diameter of 3 mm. The arcs in
each body project 0.15 mm upwards from a planar sur-
face and are separated from one another by gaps of
approximately 2.5 mm in width on the upper side to
allow magnetic beads to move into the cup and 1 mm in
width on the bottom side to allow magnetic beads to
move through the grids. Twenty-four grids are arranged
in rows, whose pitch matches the pitch of standard 384-
well plates. The fabricated film was bound to the inner
surface of the thin glass plate. On this film, droplets were
spontaneously self-centered on the generated pattern,
which enabled parallel sample processing by MAGrahder.
Robotic magnetic bead handling instrument
A SHOTMASTER 300 desktop robot was converted
into MAGrahder by mounting a magnetic head.
Twenty-four neodymium magnet rods (Magfine, 1.5
mm × 20 mm 2910 Gauss) were installed on the head,
whose pitch matches the pitch of standard 96-well
plates. With a specially designed software program, the
non-contact magnetic power transmission can be
adapted to achieve optimal output.
Synthesis of 3’-end homopolymer-tailed cDNA from
single cells
Plasma cells were isolated from popliteal lymph nodes of
egg albumin-immunized mice using a CD138+ plasma
cell isolation kit as previously described [18]. Single
plasma cells were captured with a standard micromani-
pulator mounted on an inverted microscope and sus-
pended in 10 μl of lysis/binding solution (100 mM Tris
HCl, pH 7.5, 500 mM LiCl, 1% lithium dodecyl sulfate,
5 mM dithiothreitol) containing 5 μg of oligo-dT mag-
netic beads. The preparation of 3’-end homopolymer-
tailed cDNA from single plasma cells was performed by
the MAGrahd method as described previously [18].
Briefly, 3 μl each of single-cell lysate containing oligo-
dT magnetic beads, washing solution 1, washing solu-
tion 2, reverse transcription solution, washing solution
3, terminal transferase solution, washing solution 4 and
PCR solution were dispensed onto the fabricated film of
the MAGrahd reactor tray. After all the regents were
spotted onto the film, cDNA synthesis and homopoly-
mer-tailing reaction were conducted with MAGrahder
by touching neodymium permanent magnet rods to the
opposite side of the thin glass surface of the MAGrahd
reactor tray above the drops.
Amplification of VH and VL genes from single plasma
cells
VH and VL chain genes were amplified by single cell-
based 5’-RACE PCR with 3’-end homopolymer-tailed
cDNAs as templates. Briefly, the first round of PCR was
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performed with a dC13 forward primer (5’-
CGGTACCGCGGGCCCGGGATCCCCCCCCCCCC
CDN-3’) and a mixture of reverse primers (P0) specific
for the respective IgG (5’-ACCYTGCATTTGAACT
CCTTGCC-3’) and IgK (5’-ACTGCCATCAATCTTC-
CACTTGACA-3’) constant regions. PCR was performed
using PrimeStar DNA polymerase in 1× PrimeStar GC
buffer with the BIO-RAD MyCycler (35 cycles with
denaturation at 95°C for 30 s, annealing and strand
elongation at 68°C for 90 s and a final extension at 72°C
for 3 minutes). The resulting PCR mixtures were next
diluted at a 1:10 ratio with water, and 1 μl of each was
used for the second round of PCR. The second round of
PCR was performed with a forward primer (P1) that
annealed to the dC13 forward primer used in the first
PCR and the respective nested reverse primer (P2) spe-
cific for the IgG (5’-CTGGACAGGGATCCA-
GAGTTCCA-3’) or IgK (5’-ACTGAGGCACCTCCA
GATGTTAACT-3’) constant regions.
Preparation of DNA fragments for pilot experiment
A mock DNA sequence was amplified by PCR from
pEGFP-N1 (Takara-Clontech) with the primers 5’-
CTTCGAATTCTGCAGTCGACGGTACCGCGGGCC
GGGGTGGTGCCCATCCTGG -3’ and 5’-CTGGA-
CAGGGATCCAGAGTTCCATGCCGAGAGTGATC
CCG -3’ (underlined sequences are homologous to the
GFP gene). The mock DNA sequence (727 bp) consisted
of the upper primer-derived sequence (P1 region), a
portion of the GFP gene sequence (712-1372 of nucleo-
tide accession number: U55762), and the lower primer-
derived sequence (P2 region). The mock DNA was used
as a nonspecifically amplified DNA sequence for the
pilot experiment. The mouse V gene fragment consisted
of the upper primer-derived sequence (P1 region), the
poly dC/dG sequence (T1 region), the mouse IgG V
region, part of IgG constant region (T2 region) (560-600
of nucleotide accession number: AB097849) and the
lower primer-derived sequence (P2 region) (601-623 of
nucleotide accession number: AB097849). The amplified
DNA fragments were purified using a spin column. A
schematic illustration of the DNA fragment and Ig-cas-
settes is found in Figure 2A.
TS-jPCR
After the second round of PCR, 1 μl of the PCR solution
was mixed with 1 μl of TdT solution (1 × PrimeStar GC
buffer containing 0.2 mM of each dNTP and 2 units of
TdT) and incubated at 37°C for 30 min for 3’-end ran-
dom nucleotide tailing. TdT was heat inactivated at 94°
C for 5 min.
The random nucleotide-tailed PCR products (50-100
ng) were mixed with 20 μl of PCR mixture containing
10 ng of the IgH- or IgK-cassette, 0.2 mM of each
dNTP, 1.25 U of PrimeStar DNA polymerase and 400
nM of the P3 and P4 PCR primers (5’-AGA-
GAAACCGTCTATCAGGGCGATGGC-3’ and 5’-AGA-
GACCCTTTGACGTTGGAGTCCACG-3’) in 1×
PrimeStar GC buffer. TS-jPCR was performed for 5
cycles with denaturation at 95°C for 30 s and annealing
and strand elongation at 70°C for 240 s, followed by 25-
30 cycles with denaturation at 95°C for 30 s, primer
annealing at 60°C for 30 s and primer extension at 72°C
for 1 min.
Expression of recombinant mouse monoclonal antibodies
The unpurified TS-jPCR products (1 μl each) of paired
IgH- and IgL-expression constructs were co-transfected
with FuGENE HD Transfection Reagent (Roche) into
293FT cells grown in 96-well culture dishes without the
risk of endotoxin contamination derived from the plas-
mid purification step out of bacteria. Two days after
transfection, the cell culture supernatants were analyzed
for the secretion of recombinant antibodies. Antibody
concentration and antibody reactivity were determined
by a sandwich enzyme-linked immunosorbent assay
(ELISA) as described previously [18].
Sequence Analysis
The nucleotide sequence was determined using an
Applied Biosystems 373 DNA sequencer with a BigDye
Terminator v3.1 Cycle Sequence Kit (Applied Biosys-
tems). The alignment of the V-(D)-J sequence was per-
formed using IMGT/V-QUEST http://imgt.cines.fr/
IMGT_vquest/share/textes/[20].
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PCR: polymerase chain reaction; TS-jPCR: target-selective joint PCR; GFP:
green fluorescent protein; V: immunoglobulin variable; VL: immunoglobulin
light chain variable; VH: immunoglobulin heavy chain variable; 5’-RACE PCR:
rapid amplification of 5’cDNA ends polymerase chain reaction; ELISA:
enzyme-linked immunosorbent assay; IgG: immunoglobulin gamma; IgK:
immunoglobulin kappa; TdT: terminal deoxynucleotidyl transferase, RLU:
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